We are excited to participate in the European Human Genetics (ESHG) 2024 conference, where we will showcase our latest advancements in genetic analysis software. Attendees can visit Booth #428 to explore tools like VarSeq, VS-CNV, VSClinical, VSPipeline, and VSWarehouse. These solutions, aligned with ACMG and AMP Guidelines, offer powerful options for genomic analysis. Live demos will highlight our newest pharmacogenomics solution, VSPGx, based on CPIC guidelines. Don’t miss this opportunity to meet our expert team members and receive exclusive t-shirts.
Find us in Booth #428
Demo Schedule
- Saturday, June 1:
- 10:10 – PGx: Pharmacogenomics Workflow
- 12:10 – VarSeq Dx: Using the VarSeq Suite as a Medical Device Under IVDR
- 12:40 – Whole Genome Analysis with Long Read Data
- 13:10 – Calling CNV with Twist Exome 2.0
- 13:30 – NGS Enterprise Capabilities – Automation, Warehousing, Continuous Improvement 16:10 – Carrier Status Analysis in VarSeq
- 18:10 – Somatic NGS Workflow with VarSeq – Streamlining Tertiary Analysis with Oncogenicity Classifier and Golden Helix CancerKB
- Sunday, June 2:
- 10:10 – Somatic NGS Workflow with VarSeq – Streamlining Tertiary Analysis with Oncogenicity Classifier and Golden Helix CancerKB
- 12:10 – PGx: Pharmacogenomics Workflow
- 12:40 – VarSeq Dx: Using the VarSeq Suite as a Medical Device Under IVDR 13:10 – Whole Genome Analysis with Long Read Data
- 13:40 – Carrier Status Analysis in VarSeq
- 15:40 – NGS Enterprise Capabilities – Automation, Warehousing, Continuous Improvement
- 16:40 – Calling CNV with Twist Exome 2.0
- Monday, June 3:
- 10:10 – Carrier Status Analysis in VarSeq
- 12:00 – 13:00 Corporate Satellite Talk (Room: New York 1): Golden Helix: A Clinical Interpretation Solution for Next-Generation Sequencing
- 13:30 – VarSeq Dx: Using the VarSeq Suite as a Medical Device Under IVDR
- 15:40 – PGx: Pharmacogenomics Workflow
- 16:10 – Calling CNV with Twist Exome 2.0
- 16:40 – NGS Enterprise Capabilities – Automation, Warehousing, Continuous Improvement
Corporate Satellite Talk
GOLDEN HELIX – A CLINICAL INTERPRETATION SOLUTION FOR NEXT GENERATION SEQUENCING LABS
Monday, June 3, 12:00 – 13:00, Room: New York 1
Presented by: Dr. Andreas Scherer, President and CEO & Nathan Fortier, PhD, Golden Helix Director of Research, Jennifer Dankoff, PhD, Field Application Scientist
Guest Speaker: Tina Han, Director of Applications & Business Development Twist Biosciences
Guest Speaker: David Stucki, Field Application Support Manager, PacBio
Join us for an insightful discussion on our latest advancements in the clinical interpretation of next-generation sequencing data. Discover our high-quality variant analysis and interpretation capabilities that scale efficiently. Implement ACMG and AMP guidelines for variant interpretation, directly call CNVs in target regions, exomes, and whole genomes, and utilize repeatable clinical interpretation workflows. Recently, we unveiled our pharmacogenomics solution VSPGx, based on the CPIC guidelines. We will share some of the VSPGx capabilities in further detail.
We are looking forward to seeing you all there!
